|
IQVIA™ Real-World Insights Bibliography
| Health economic consequences of the use of irbesartan in patients with type 2 diabetes, hypertension and nephropathy in Switzerland. |
| Author(s): Frei A, Palmer AJ, Burnier M, Hess B |
| Affiliations(s): |
Publication(s): Schweiz Rundsch Med Prax.15;95:401-8. German.
|
| Document Type(s): Manuscript in preparation, |
| Countries: |
C:
Y: |
Nephrology,
2006 |
|
L:
A: |
English
|
|
 |
| |
| |
| Potential savings with everolimus with reduced-dose cyclosporine compared to mycophenolate motefil with full dose cyclosporine in de novo renal transplant recipients in China. |
| Author(s): Yang X, Ethgen O, Wang W, Lian R, Ricci JF, Spaepen E et al. |
| Affiliations(s): |
Publication(s): ISPOR 2nd Asia-Pacific Congress, Shanghai, China
|
| Document Type(s): Poster, |
| Countries: China, |
C:
Y: |
Nephrology,
2006 |
|
L:
A: |
English
|
|
|
| |
| |
| Cost-effectiveness of sirolimus therapy with early cyclosporin withdrawal versus long-term cyclosporin therapy in Australia |
| Author(s): Gordois A, Nobes M, Toohey M, Russ G |
| Affiliations(s): |
Publication(s): Clinical Transplantation. 20:4, 526?536
|
| Document Type(s): Article, |
| Countries: Australia, |
C:
Y: |
Nephrology,
2006 |
|
L:
A: |
English
Cost effectiveness, |
|
|
| |
| |
| A regional Asian analysis of the cost-effectiveness of early irbesartan treatment verus conventional antihypertension treatment, and late irbesartan treatment in patients with type 2 diabetes hypertension and kidney disease |
| Author(s): Annemans L, Demarteau N, Hu S, Lee TJ, Morad Z, Thanom S, Yang WC. |
| Affiliations(s): |
Publication(s): ISPOR 2nd Asia-Pacific conference, Worldfield Convention Hotel, Shanghai, China
|
| Document Type(s): Poster, |
| Countries: |
C:
Y: |
Endocrinology, Nephrology,
2006 |
|
L:
A: |
English
|
|
|
| |
| |
 5 of 5
|
|
